References

1. Glycosylated Fibronectin point-of-care test for diagnosis of pre-eclampsia in a low-resource setting: a prospective Southeast Asian population study. Nagalla et al. 2020. BJOG. – Read here

2.  Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study.  Huhn, E. A. et al. 2020. BMC Pregnancy and Childbirth. – Read Here

3. Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia. Rasanen et al. 2015. AJOG. – Read Here